The research will provide insights into the development of potential treatments for neurological diseases and obesity, among other human conditions. Visualization of all cell clusters coloured by major cell types. A total of 113 cell clusters were identified in the...

央广网重庆1月26日消息 1月25日，重庆精准生物技术有限公司（以下简称：重庆精准生物）自主研发的CAR-T细胞产品pCAR-19B细胞自体回输制剂Ⅱ期注册临床试验启动，该产品将用于治疗儿童、青少年复发/难治性B细胞急性淋巴细胞白血病（B-ALL）。 同济医院启动会（央广网发 重庆精准生物技术有限公司供图） 该产品于2019年2月获儿童B-ALL适应症注册临床默示许可，是国内首个针对该适应症进入到II期注册临床的CAR-T产品，也是国内首个针对该适应症的人源化设计的CAR-T产品，在前期临床研究中展现出良好的安全性和有效性。...

Innoforce (“INF”), a biopharmaceutical manufacturing & development company, announced today the completion of a 1 billion CNY ($156.6M) Series A financing, with the closing of an additional 375M CNY ($58.7M) following the first tranche of 625M CNY ($96M) completed...

On 2021 May 15, Synceres Biotechnology (Shenzhen) Co., Ltd. and Angel yeast Co., Ltd. officially announced the joint foundation of Hubei angel senris Biotechnology Co., Ltd.  The CEO of Synceres, Xibin Zhou ,and Xiong Tao, CEO of Angel, signed a joint venture...

DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of...

BEVERLY, Mass. & CANTON, Mass.--(BUSINESS WIRE)--Sage Science, a developer of products for improving sample preparation processes in life science applications, and Universal Sequencing Technology today announced a distribution agreement to improve scientists’...